Back to search

Article

New onset rheumatoid arthritis with refractory hyper-eosinophilia associated with inactivated COVID-19 vaccine

2022-01-06

Abstract excerpt

COVID-19 vaccines are considered one of the primary strategies for countering the pandemic. While mRNA based and viral vector-based vaccines have been predominantly used, inactivated SARS-CoV-2 vaccines are being manufactured in countries such as China and India. Post approval, rare but serious adverse events such as myocarditis and stroke have been observed with mRNA based and viral vectored COVID-19 vaccines. In...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
95a6c1ca-c54d-5dfe-9ca2-729a1e0582e2
DOI
10.21203/rs.3.rs-1236248/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
New onset rheumatoid arthritis with refractory hyper-eosinophilia associated with inactivated COVID-19 vaccineDOI 10.21203/rs.3.rs-1236248/v1
Safety of Coronavac and ChAdOx1 Vaccines Against SARS-CoV-2 in Patients with Rheumatoid Arthritis Data from the Brazilian Multicentric Study SaferSemantic proximity
Rapid Progressive Systemic Sclerosis Following mRNA COVID-19 VaccinationSemantic proximity
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patientsSemantic proximity
Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this conditionSemantic proximity
The Impact of The COVID-19 Pandemic on The Incidence of Adult and Pediatric Inflammatory ArthritisSemantic proximity
Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseasesSemantic proximity
Immunogenicity and safety of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseasesSemantic proximity
Anti-SARS-CoV-2 immunogenicity decay and incident cases six months after Sinovac-CoronaVac inactivated vaccine in autoimmune rheumatic diseases patients: phase 4 prospective trialSemantic proximity
Gene Expression Profile of Post COVID-19 Rheumatoid Arthritis Development- Cross Sectional Study at Basrah, IraqSemantic proximity
Knee Arthritis After COVID-19 Vaccination: A Seven-Cases SeriesSemantic proximity
Immuno-inflammatory rheumatic diseases and COVID-19: analysis of clinical outcomes according to the data of the register of patients of the Novosibirsk region receiving therapy with genetically engineered biological drugsSemantic proximity
C-C Chemokine Receptor Type 5 Links COVID-19, Rheumatoid Arthritis, and HydroxychloroquineSemantic proximity
Select a neighboring publication to make it the new centre.